Total : 4
| No. | Title | Attached | Date | View |
|---|---|---|---|---|
| 4 | Samyang Holdings Biopharmaceuticals Division’s PCL Filler “Lafullen” Proven for Safety and Efficacy | 2022. 05. 13 | 44 | |
| 3 | Samyang Holdings Biopharmaceuticals Division Acquires Approval for Cosmetic Dermal Filler ‘Lafullen’ | 2021. 12. 03 | 61 | |
| 2 | Samyang Holdings Files for Marketing Authorization for Cosmetic Surgery Filler “Lafullen” | 2021. 12. 03 | 53 | |
| 1 | Information about PR Tab | 2020. 03. 05 | 128 |
295, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea TEL +82-2-2157-9111 FAX +82-2-2157-9063
Privacy Policy COPYRIGHTⓒ2025 SAMYANG HOLDINGS CORPORATION. ALL RIGHTS RESERVED.
Privacy Policy COPYRIGHTⓒ2025 SAMYANG HOLDINGS CORPORATION. ALL RIGHTS RESERVED.